AstraZeneca and Daiichi Sankyo got U.S. approval to expand the label of their jointly developed Enhertu drug in combination with another medicine as an initial treatment for a type of breast cancer.

Dow Jones Top Company Headlines at 1 AM ET: CoreWeave's Staggering Fall From Market Grace Highlights AI Bubble Fears | CEOs ... CoreWeave's Staggering Fall From Market Grace Highlights AI Bubble Fears ...

Dow Jones Top Markets Headlines at 1 AM ET: U.S. Stocks Slump Ahead of Jobs Data | Two ... A slump in Broadcom and other AI-related stocks weighed on the tech-heavy Nasdaq composite. Two Fed officials ...

Gucci owner Kering will receive $690 million for a majority stake in a Fifth Avenue property in a deal with private-equity group Ardian, as the luxury group continues to unload assets to bolster its ...

DBS Group's shares rose as high as 1.3% to 56.00 Singapore dollars, equivalent to US$43.43, while OCBC climbed as high as 0.8% to S$19.45 early Tuesday. DBS and OCBC have since pared gains and were ...

Holcim said it will buy a majority stake in Peruvian building-materials producer Cementos Pacasmayo, in a deal that values the target as a whole at $1.5 billion. The Swiss building-materials supplier ...

Dow Jones Top Energy Headlines at 12 AM ET: Oil Futures Fall Further on Oversupply Concerns | Rival ... Oil futures settled lower with expected inventory builds and continued efforts to end the Russia ...

Dow Jones Top Financial Services Headlines at 12 AM ET: High-Speed Traders Are Feuding Over a Way to Save 3.2 Billionths of a Second | JPMorgan ... High-Speed Traders Are Feuding Over a Way to Save ...

European stock futures traded lower early Tuesday. Asian stock indexes tracked Wall Street lower; the dollar and Treasury yields were little changed; while oil and gold futures fell. Stock futures ...

Broadcom's steepest three-day drop in over five years has the chip maker falling down the ranks of the largest U.S. companies.